Thursday, March 11, 2010
Background on Avlar BioVentures
Avlar was founded in 1999 by Alan Goodman and Daniel Roach and
manages Avlar Fund II (£43m) and the First Cambridge Gateway Fund (£35m). Avlar has
invested in eighteen companies across a range of sub-sectors of the
bioscience industries. Ten are still private, two have been merged,
three have been bought by public companies, two have been sold for cash
and two listed on the public markets. Prior to the formation
of Avlar Messrs Roach and Goodman co-founded or seed financed nine life
science companies. Seven of these were listed on recognized Stock
Exchanges producing highly profitable realizations. These included
Acambis, Chiroscience, Core, Salix and Oxford Biomedica.
|
|
Avlar | Goodman & Roach (pre Avlar) |
Total |
|
Founded |
18 | 9 | 27 |
|
Private |
10 | 2 | 12 |
|
Merged |
2 | 2 | |
|
Acquired by public companies |
3 | 3 | |
| Sold for cash |
2 | 2 | |
| IPO |
2 | 7 | 8 |
